| Literature DB >> 32888803 |
Ryosuke Shintani1, Motohiro Sekino2, Takashi Egashira3, Rintaro Yano3, Haruka Inoue4, Sojiro Matsumoto3, Ushio Higashijima3, Shuhei Matsumoto4, Tsuyoshi Yonekura5, Tetsuya Hara6.
Abstract
Kounis syndrome is an anaphylactic reaction leading to acute coronary syndrome. The acute treatment of anaphylaxis is epinephrine; however, epinephrine may cause coronary vasoconstriction, reduce coronary blood flow, increase myocardial oxygen demand, and worsen myocardial ischemia. On the other hand, coronary vasodilation, a treatment for acute coronary syndrome, can aggravate hypotension in patients with anaphylaxis. Herein, the authors report a case of type II Kounis syndrome, with vasospasm in a patient with coronary disease, requiring the administration of epinephrine and a coronary vasodilator for resuscitation. The authors administered intravenous epinephrine continuously from lower dosages and performed delicate titration. The coronary vasodilator nicorandil, which has little effect on hemodynamics, also was administered. These treatments improved hemodynamics without complications. Circulatory management that considers both anaphylaxis and coronary lesions is crucial to improve prognosis in this syndrome.Entities:
Keywords: Kounis syndrome; anaphylaxis; coronary vasospasm; epinephrine; nicorandil; therapeutic management
Mesh:
Substances:
Year: 2020 PMID: 32888803 DOI: 10.1053/j.jvca.2020.08.009
Source DB: PubMed Journal: J Cardiothorac Vasc Anesth ISSN: 1053-0770 Impact factor: 2.628